Survival after the Onset of De Novo Donor Specific Anti-HLA Antibodies in a Consecutive Series of "Low-Risk" Renal Transplant Patients

被引：0

作者：

Everly, M. J. ^{[1
,2
]}

Rebellato, L. M. ^{[3
]}

Ozawa, M. ^{[1
,2
]}

Briley, K. P. ^{[3
]}

Catrou, P. G. ^{[3
]}

Bolin, P. ^{[3
]}

Kendrick, W. T. ^{[4
]}

Kendrick, S. A. ^{[4
]}

Haisch, C. E. ^{[3
]}

Harland, R. C. ^{[3
]}

Terasaki, P. I. ^{[1
]}

机构：

[1] Terasaki Fdn, Los Angeles, CA USA

[2] One Lambda Inc, Los Angeles, CA USA

[3] E Carolina Univ, Brody Sch Med, Greenville, NC USA

[4] Eastern Nephrol & Associates, Greenville, NC USA

来源：

AMERICAN JOURNAL OF TRANSPLANTATION | 2012年 / 12卷

关键词：

D O I：

暂无

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

180

引用

页码：80 / 80

页数：1

共 50 条

[31] De novo donor-specific anti-HLA antibodies are a risk factor for graft loss in DCD liver transplantation
Andacoglu, Oya
Ellis, Thomas
D'Alessandro, Anthony M.
Foley, David
Powell, Amy
Leverson, Glen E.
Lucey, Michael R.
Musat, Alexandru I.
HEPATOLOGY, 2013, 58 : 211A - 211A
[32] ANTIBODY MEDIATED REJECTION AFTER HEART TRANSPLANTATION WITH DE NOVO DONOR SPECIFIC ANTI-HLA ANTIBODIES: CASE REPORT
Pashkova, I. A.
Porhanov, V. A.
Gilevich, I., V
Kosmacheva, E. D.
Kruberg, L. K.
VOX SANGUINIS, 2013, 105 : 298 - 298
[33] DONOR SPECIFIC ANTI-HLA IGA ANTIBODIES AND GRAFT SURVIVAL AFTER KIDNEY TRANSPLANTATION
Arnold, Marie-Luise
Bach, Christian
Heinemann, Falko M.
Dick, Andrea
Spriewald, Bernd M.
HLA, 2018, 91 (05) : 358 - 358
[34] Effect of Preformed or De Novo Anti-HLA Antibodies on Function and Graft Survival in Kidney Transplant Recipients
de Sousa, Marcos Vinicius
Goncalez, Ana Claudia
Zollner, Ricardo de Lima
Mazzali, Marilda
ANNALS OF TRANSPLANTATION, 2018, 23 : 457 - 466
[35] Effect of SARS-CoV-2 infection on anti-HLA antibodies and de novo donor specific antibodies incidence in lung transplant recipients
Zajacova, Andrea
Dvorackova, Eliska
Casas-Mendez, Luis Fernando
Vychytilova, Katerina
Rakita, Dmitry
Valentova-Bartakova, Lucie
Svorcova, Monika
Slavcev, Antonij
Fila, Libor
Lischke, Robert
Havlin, Jan
TRANSPLANT IMMUNOLOGY, 2023, 81
[36] COMPLEMENT- AND NON-COMPLEMENT-BINDING DE NOVO DONOR SPECIFIC ANTI-HLA ANTIBODIES AND KIDNEY ALLOGRAFT SURVIVAL
Guerville, Florent
Guidicelli, Gwendaline
Lepreux, Sebastien
Wiebe, Chris
Thaunat, Olivier
Dubois, Valerie
Visentin, Jonathan
Bachelet, Thomas
Morelon, Emmanuel
Nickerson, Peter
Merville, Pierre
Taupin, Jean-Luc
Couzi, Lionel
TRANSPLANT INTERNATIONAL, 2015, 28 : 119 - 119
[37] De novo anti-HLA donor-specific antibodies not diagnostic for ABMR are associated with a higher risk of persistent/recurrent TCMR and graft dysfunction in kidney transplant patients
Juma, Y. S.
Kallakury, B. V.
Kwon, D.
Timofeeva, O.
HUMAN IMMUNOLOGY, 2023, 84 : 111 - 111
[38] Development of De Novo Anti-HLA Antibodies in Pediatric Heart Transplant Recipients
Chen, C. K.
Manlhiot, C.
Conway, J.
Allain-Rooney, T.
McCrindle, B. W.
Tinckam, K.
Dipchand, A. I.
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2013, 32 (04): : S193 - S193
[39] Prevalence and Impact of Reformed and De Novo Anti-HLA Donor-Specific Antibodies in Liver Transplantation
Papachristou, M.
Fylaktou, A.
Daoudaki, M.
Cholongitas, E.
Karampatakis, T.
Anastasiou, A.
Chatzika, G.
Makrovasili, F.
Vagiotas, L.
Karakasi, K.
Fouzas, I.
TRANSPLANTATION PROCEEDINGS, 2019, 51 (02) : 424 - 428
[40] Anti-HLA antibodies monitoring in kidney transplant recipients: high prevalence of donor specific anti-HLA class II antibodies
Ares, O. M.
Ruiz, A. T.
Tagarro, E. F.
Samper, R. G.
Rodriguez, R. G.
Palop, F. H.
Valentin, M. A. P.
Estupinan, R. S.
Perez, J. C. R.
Andres, M. D. C.
IMMUNOLOGY, 2012, 137 : 736 - 737

← 1 2 3 4 5 →